Shukra Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	567.27	325.87	745.73	588.34	204.86
Other Revenue	-	-	-	6.59	-0
Revenue	567.27	325.87	745.73	594.93	204.86
Revenue Growth (YoY)	74.08%	-56.30%	25.35%	190.41%	82.97%
Cost of Revenue	158.49	82.92	445.34	454.25	105.17
Gross Profit	408.78	242.95	300.39	140.68	99.69
Selling, General & Admin	70.37	72.02	81.76	53.83	55.4
Other Operating Expenses	5.19	16.36	2.03	21.88	14.94
Operating Expenses	109.99	118.43	104.29	94.09	86.96
Operating Income	298.8	124.52	196.09	46.59	12.73
Interest Expense	-10.93	-5.21	-2.76	-2.56	-2.81
Interest & Investment Income	-	14.79	5.59	0.64	0.31
Other Non Operating Income (Expenses)	-0	-0.74	-0.09	-0.25	-0.05
EBT Excluding Unusual Items	287.87	133.37	198.83	44.42	10.18
Pretax Income	287.87	133.37	198.83	44.42	10.18
Income Tax Expense	67.28	37.61	13.46	0.35	2.67
Net Income	220.58	95.75	185.37	44.07	7.51
Net Income to Common	220.58	95.75	185.37	44.07	7.51
Net Income Growth	130.37%	-48.35%	320.68%	486.98%	299.10%
Shares Outstanding (Basic)	441	438	438	67	63
Shares Outstanding (Diluted)	441	438	438	67	63
Shares Change (YoY)	0.75%	-	551.03%	7.38%	-
EPS (Basic)	0.50	0.22	0.42	0.66	0.12
EPS (Diluted)	0.50	0.22	0.42	0.66	0.12
EPS Growth	128.66%	-48.35%	-35.38%	446.67%	299.10%
Free Cash Flow	-117.99	51.75	-69.57	-13.22	64.39
Free Cash Flow Per Share	-0.27	0.12	-0.16	-0.20	1.03
Dividend Per Share	0.010	0.010	0.100	0.013	0.013
Dividend Growth	-	-90.00%	700.00%	-	-
Gross Margin	72.06%	74.55%	40.28%	23.65%	48.66%
Operating Margin	52.67%	38.21%	26.30%	7.83%	6.21%
Profit Margin	38.88%	29.38%	24.86%	7.41%	3.66%
Free Cash Flow Margin	-20.80%	15.88%	-9.33%	-2.22%	31.43%
EBITDA	333.23	154.57	216.59	64.96	29.35
EBITDA Margin	58.74%	47.43%	29.04%	10.92%	14.33%
D&A For EBITDA	34.43	30.05	20.5	18.38	16.62
EBIT	298.8	124.52	196.09	46.59	12.73
EBIT Margin	52.67%	38.21%	26.30%	7.83%	6.21%
Effective Tax Rate	23.37%	28.20%	6.77%	0.79%	26.26%
Revenue as Reported	613.12	367.94	773.88	600.3	205.67
Advertising Expenses	-	3.63	21.21	0.1	0.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.